Jones Lee

Sharma Ojasvi, Jones Lee, Sii Freda, Whittaker Jonathan, Dulku Simon, Lee Graham et al.

This study found glaucoma patients in a COVID-19 backlog experienced significant vision loss and increased risk classification using Glauc-Strat-Fast, highlighting the tool's utility and the impact of delayed care.

Konstantakopoulou Evgenia, Jones Lee, Nathwani Neil, Gazzard Gus

Studying optometrist-delivered SLT, research found it acceptable and beneficial for the NHS, but requires standardized training, robust governance, and specific clinical prerequisites for safe implementation.

Jones Pete R, Campbell Peter, Callaghan Tamsin, Jones Lee, Asfaw Daniel S, Edgar David F et al.

This study found tablet-based home visual field monitoring in glaucoma patients is accurate, viable, and provides clinically useful data, reducing measurement error compared to clinic tests alone.

Enoch Jamie, Jones Lee, Taylor Deanna J, Bronze Carol, Kirwan James F, Jones Pete R et al.

This review found glaucoma significantly impairs low-light vision, glare tolerance, and dark adaptation, impacting quality of life even in early stages, despite limited performance differences in daily tasks.

Jones Lee, Garway-Heath David F, Azuara-Blanco Augusto, Crabb David P

This study found patient-reported outcomes weren't sensitive enough to detect treatment effects in early glaucoma, but did differentiate stable from progressing patients, suggesting limited utility as primary trial endpoints.

Jones Lee, Bryan Susan R, Miranda Marco A, Crabb David P, Kotecha Aachal

This study found virtual glaucoma monitoring yielded visual field outcomes equivalent to standard care, supporting its implementation for efficient hospital eye services.